CD14+HLA-DR+CCR2+ but not CD14+CD163+CCR2− monocytes were higher in RA subjects versus healthy controls (4.08 ± 4.46 vs. 1.55 ± 1.73, p < 0.01). Here, CCR2 is linked to rheumatoid arthritis.